Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma
type: MedicalStudy
description: The Efficacy and Safety of Irinotecan Liposomes Combined With Cisplatin/Carboplatin for Gastrointestinal Pancreatic Neuroendocrine Carcinoma: a Real-world Study
status: NOT_YET_RECRUITING
study design: INTERVENTIONAL
phase: PHASE4
start date: 2024-07-01
end date: 2028-09-01
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT06485739
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: First Affiliated Hospital Xi'an Jiaotong University
study subject: Neuroendocrine Tumors
keywords: PHASE4
keywords: INTERVENTIONAL
keywords: NOT_YET_RECRUITING
keywords: Neuroendocrine Tumors

AI Analytics
type: Organization